(S)-4-(2-Chloropyrimidin-4-yl)-3-methylmorpholine → (S)-1-(2,2-difluoroethyl)-3-(4-(4-(3-methylmorpholino)pyrimidin-2-yl)phenyl)urea

HRID 1771562Notes

Reaction equation

HRID 1771562 reaction equation
Cl[C:2]1[N:7]=[C:6]([N:8]2[CH2:13][CH2:12][O:11][CH2:10][C@@H:9]2[CH3:14])[CH:5]=[CH:4][N:3]=1.[F:15][CH:16]([F:37])[CH2:17][NH:18][C:19]([NH:21][C:22]1[CH:27]=[CH:26][C:25](B2OC(C)(C)C(C)(C)O2)=[CH:24][CH:23]=1)=[O:20]>>[F:15][CH:16]([F:37])[CH2:17][NH:18][C:19]([NH:21][C:22]1[CH:27]=[CH:26][C:25]([C:2]2[N:7]=[C:6]([N:8]3[CH2:13][CH2:12][O:11][CH2:10][C@@H:9]3[CH3:14])[CH:5]=[CH:4][N:3]=2)=[CH:24][CH:23]=1)=[O:20]

Participants

3

Reactant 2

HCID 72942067(S)-4-(2-Chloropyrimidin-4-yl)-3-methylmorpholine2×HCID 866911471-(2,2-Difluoroethyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea2×

Product 1

HCID 53379664(S)-1-(2,2-difluoroethyl)-3-(4-(4-(3-methylmorpholino)pyrimidin-2-yl)phenyl)urea

Procedure

Method as described for example 49 using (S)-4-(2-chloropyrimidin-4-yl)-3-methylmorpholine (intermediate 3) and 1-(2,2-difluoroethyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea (intermediate 20). Purified by prep HPLC at high pH to afford the title compound. (68 mg, 38%).

Workup

  1. customPurified by prep HPLC at high pH

Sources & evidence

ORD record
ord-a85d9ece82784979a1b9089c5455de59
Source dataset
uspto-grants-2016_02
Patent number
US09249129B2

Reaction notes

Loading…